NDRG2 silencing led to a decrease in Aβ1-42 (the predominant form of amyloid β found in AD) in neuroblastoma cells, and overexpression to an increase in Aβ1-42, implicating NDRG2 in the formation of senile plaques. The gene discussed is NDRG2; the disease is neuroblastoma.